MAP2K3 Produits
(Mitogen-Activated Protein Kinase Kinase 3 (MAP2K3))
Catégories
antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.
Catégories MAP2K3 en vedette
MAP2K3 Anticorps
High quality antibodies with extensive validation data.
MAP2K3 Kits ELISA
Reliable ELISA kits for a wide range of species.
MAP2K3 Protéines
Proteins for various applications incl. WB, ELISA, IF etc.
MAP2K3 recommandé Anticorps
- (1)
- (7)
- (9)
- (9)
MAP2K3 recommandé Kits ELISA
MAP2K3 recommandé Protéines
- (1)
- (1)
- (1)
Dernières publications sur nos produits MAP2K3
: "Silencing Ras-Related C3 Botulinum Toxin Substrate 1 Inhibits Growth and Migration of Hypopharyngeal Squamous Cell Carcinoma via the P38 Mitogen-Activated Protein Kinase Signaling Pathway." dans: Medical science monitor : international medical journal of experimental and clinical research, Vol. 24, pp. 768-781, (2018) (PubMed).: "MAPK kinase 10.2 promotes disease resistance and drought tolerance by activating different MAPKs in rice." dans: The Plant journal : for cell and molecular biology, Vol. 92, Issue 4, pp. 557-570, (2018) (PubMed).
: "MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase 3." dans: BMC cancer, Vol. 13, pp. 469, (2013) (PubMed).
: "MAP2K3 is associated with body mass index in American Indians and Caucasians and may mediate hypothalamic inflammation." dans: Human molecular genetics, Vol. 22, Issue 21, pp. 4438-49, (2013) (PubMed).
: "MAP-ing glioma invasion: mitogen-activated protein kinase kinase 3 and p38 drive glioma invasion and progression and predict patient survival." dans: Molecular cancer therapeutics, Vol. 6, Issue 4, pp. 1212-22, (2007) (PubMed).
: "Cytokine activation of p38 mitogen-activated protein kinase and apoptosis is opposed by alpha-4 targeting of protein phosphatase 2A for site-specific dephosphorylation of MEK3." dans: Molecular and cellular biology, Vol. 27, Issue 12, pp. 4217-27, (2007) (PubMed).
: "The survival kinase Mirk/dyrk1B is activated through Rac1-MKK3 signaling." dans: The Journal of biological chemistry, Vol. 280, Issue 51, pp. 42097-105, (2005) (PubMed).
: "Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase ..." dans: Molecular biology of the cell, Vol. 14, Issue 2, pp. 529-44, (2003) (PubMed).
: "Comparative studies of a new subfamily of human Ste20-like kinases: homodimerization, subcellular localization, and selective activation of MKK3 and p38." dans: Oncogene, Vol. 22, Issue 40, pp. 6129-41, (2003) (PubMed).
Synonymes et noms alternatifs relatifs à MAP2K3
mitogen-activated protein kinase kinase 3 (MAP2K3), mitogen-activated protein kinase kinase 3 (Map2k3), mitogen activated protein kinase kinase 3 (Map2k3), MAP kinase activator XMEK3 (map2k3), AW212142, MAPKK3, MEK3, MKK3, Mkk3, mMKK3b, PRKMK3, Prkmk3, SAPKK-2, SAPKK2Protein level used designations for MAP2K3
- MAP kinase kinase 3
- MAPK/ERK kinase 3
- MAPKK 3
- MEK 3
- SAPK kinase 2
- dual specificity mitogen-activated protein kinase kinase 3
- stress-activated protein kinase kinase 2
- mitogen activated protein kinase kinase 3
- protein kinase, mitogen-activated, kinase 3